From: Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection
mCERADSOT | Amyloid phase | % Amyloid IHC | Dx AD (NIA-RI) | Dx AD (NIA-AA) | Braak stage | Cortical atrophy | SUVR | Dementia | BIE positivity | ||
---|---|---|---|---|---|---|---|---|---|---|---|
(Quantitative) | (Ordinal) | (Quantitative) | (Ordinal) | (Ordinal) | (Ordinal) | (Ordinal) | (Quantitative) | (Nominal) | (Nominal) | ||
P < 0.0001 | P < 0.0001 | P = 0.0005 | P < 0.0001 | P < 0.0001 | P < 0.0001 | P = 0.2518 | P < 0.0001 | P = 0.0009 | P < 0.0001 | CERAD | (Ordinal) |
P < 0.0001 | P = 0.0014 | P < 0.0001 | P < 0.0001 | P < 0.0001 | P = 0.3569 | P < 0.0001 | P = 0.0021 | P < 0.0001 | mCERADSOT | (Quantitative) | |
P < 0.0001 | P < 0.0001 | P < 0.0001 | P < 0.0001 | P = 0.6275 | P < 0.0001 | P < 0.0001 | P < 0.0001 | Amyloid Phase | (Ordinal) | ||
P = 0.0001 | P < 0.0001 | P = 0.0001 | P = 0.9266 | P < 0.0001 | P = 0.8746 | P < 0.0001 | % amyloid IHC | (Quantitative) | |||
P < 0.0001 | P < 0.0001 | P = 0.2087 | P < 0.0001 | P < 0.0001 | P < 0.0001 | AD (NIA-RI) | (Ordinal) | ||||
P < 0.0001 | P = 0.2758 | P < 0.0001 | P < 0.0001 | P < 0.0001 | AD (NIA-AA) | (Ordinal) | |||||
P = 0.4195 | P < 0.0001 | P < 0.0001 | P < 0.0001 | Braak Stage | (Ordinal) | ||||||
P = 0.1778 | P = 0.4006 | P = 0.7397 | Cortical atrophy | (Ordinal) | |||||||
P = 0.0041 | P < 0.0001 | SUVR | (Quantitative) | ||||||||
P < 0.0001 | Dementia | (Nominal) |